Objectives | Measures | T0 | T1 | T2 | T3 |
---|---|---|---|---|---|
Primary objective | |||||
 To test the effectiveness of the MARS- intervention (experimental group) in promoting medication adherence as measured by Electronic Monitoring in comparison to CAU (control group). | Data from Electronic Monitoring |  | X | X | X |
Secondary objectives patient | |||||
 To test the effectiveness of the MARS-intervention in promoting the medication adherence as measured by secondary outcome measures in comparison to CAU (control group).  To test whether the effectiveness of the MARS-intervention on medication adherence sustains after six months (T2-T3).  To asses when the MARS-intervention influences medication adherence the most. | Questionnaires patient |  |  |  |  |
Medication adherence (BAASIS) | X | X | X | X | |
Medical data patient file | Â | Â | Â | Â | |
Intra patient variability (IPV) | X | X | X | X | |
Rejection of the graft (treatment for rejection) | Â | Â | X | X | |
Graft loss | Â | Â | X | X | |
Kidney functioning (eGFR) | X | X | X | X | |
Collateral report social network | Â | Â | Â | Â | |
Medication adherence (BAASIS) | X | X | X | X | |
Collateral report Health Care Professional | Â | Â | Â | Â | |
Adherent to medication (Y/N) | X | X | X | X | |
 To test the effectiveness of the MARS-intervention (experimental group) in promoting self-management in comparison to CAU (control group). | Questionnaires patient |  |  |  |  |
Self-management skills (PiH-NL) | X | X | X | X | |
Medical data patient file | Â | Â | Â | Â | |
Blood pressure | X | X | X | X | |
Weight | X | X | X | X | |
 To test the effectiveness of the MARS-intervention (experimental group) in promoting self-efficacy in comparison to CAU (control group). | Questionnaires patient |  |  |  |  |
Self-efficacy (GSE) | X | X | X | X | |
 To test the effectiveness of the MARS-intervention (experimental group) in promoting mental health in comparison to CAU (control group). | Questionnaires patient |  |  |  |  |
Quality of life (WHOQoL-Bref) | X | X | X | X | |
Depression & Anxiety (HADS) | X | X | X | X | |
Positive & Negative affect (PANAS) | X | X | X | X | |
 To test the effectiveness of the MARS-intervention (experimental group) in promoting social support in comparison to CAU (control group). | Questionnaires patient |  |  |  |  |
Social support (MOS-SSS) | X | X | X | X | |
(heiQ- subscale Social Integration and Support) | X | X | X | X | |
(Self-developed item on who provides support in general and in relation to medication) | X | X | X | X | |
Secondary objectives important other from the social network | |||||
 To test the effectiveness of the MARS-intervention (experimental group) in promoting mental health among an important other in the social network of the patient in comparison to CAU (control group). | Questionnaires important other |  |  |  |  |
Quality of life (CarerQol-7D) | Â | X | X | X | |
Depression (PHQ-9) | Â | X | X | X | |
Anxiety (GAD-7) | Â | X | X | X | |
Positive & Negative affect (PANAS) | Â | X | X | X | |
 To test the effectiveness of the MARS-intervention (experimental group) in promoting social support among an important other in the social network of the patient in comparison to CAU (control group). | Questionnaires important other |  |  |  |  |
Social support (MOS-SSS) | Â | X | X | X | |
(heiQ- subscale Social Integration and Support) | Â | X | X | X | |
(self-developed item on who provides support) | Â | X | X | X |